Cancer Clinical Trials

252 studies are recruiting for cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 10

1. eMOTION: Examining Affective Mechanisms in Physical Activity Engagement

   This early-phase trial will test intervention strategies to influence affective mechanisms underlying physical activity and determine whether changes in those mechanisms result in change in physical activity behavior among inactive adults who are overweight or obese.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Southern California, Los Angeles, California

   Run by

   University of Southern California

   See if you can join NCT06570642 on ClinicalTrials.gov

2. Ultralow Dose PET Imaging of 18F-FDG Uptake

   The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for cancer detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 f…

   Stage

   Phase 2

   Ages

   18 to 120

   Site

   Nuclear Imaging Institute, Englewood, New Jersey

   Run by

   Akiva Mintz

   See if you can join NCT06956391 on ClinicalTrials.gov

3. Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

   This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts

   Run by

   London School of Economics and Political Science

   See if you can join NCT06997185 on ClinicalTrials.gov

4. Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

   The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

   Run by

   New Mexico Cancer Research Alliance

   See if you can join NCT03977402 on ClinicalTrials.gov

5. A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

   KB707-01 is a Phase 1/2, open-label, multicenter, dose escalation and expansion study. The study will evaluate the safety and tolerability of KB707 in adults with locally advanced or metastatic solid tumors who have progressed on standard of care therapy, cannot tolerate standard of care therapy, r…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UCLA Health, Los Angeles, California

   Locations

   15 in total

   Run by

   Krystal Biotech, Inc.

   See if you can join NCT05970497 on ClinicalTrials.gov

6. A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy

   The goal of this clinical trial is to assess whether Shengbai Oral Formula is a viable option for treatment of fatigue, pain, and neutropenia in patients undergoing their third cycle of chemotherapy.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Sutter Health, Oakland, California

   Run by

   Sutter Health

   See if you can join NCT06706752 on ClinicalTrials.gov

7. An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

   This is a prospective, single-arm, observational study capturing data from whole-body magnetic resonance imagining (WB-MRI) from up to 100,000 male and female subjects 18 years of age or older recruited at multiple clinical sites within the United States. Study subjects must meet a set of inclusion…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Hercules Research Center, Watertown, Massachusetts

   Run by

   Hercules

   See if you can join NCT06212479 on ClinicalTrials.gov

8. A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

   Building upon the results of a single-arm trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET), this trial is a randomized-controlled biobehavioral pilot trial of GET versus a time-and attention matched control (Instr…

   Stage

   Not phased

   Ages

   18 to 39

   Site

   University of California, Irvine, Irvine, California

   Run by

   University of California, Irvine

   See if you can join NCT06338475 on ClinicalTrials.gov

9. Addressing Tetrachloroethylene Exposure in an Impacted Community

   Groundwater in Martinsville, IN, is contaminated by volatile organic compounds (VOCs), tetrachloroethylene (PCE) and trichloroethylene (TCE). Indoor air in some residential and commercial buildings is also contaminated with PCE and TCE. This study is being conducted to better understand the impact …

   Stage

   Not phased

   Ages

   18 to 99

   Site

   Purdue University, West Lafayette, Indiana

   Run by

   Purdue University

   See if you can join NCT05819996 on ClinicalTrials.gov

10. Prospective Study of oncRNA Stratification of Cancer by Size and Stage

    Cancer strikes about one in three women and one in two men in the U.S. and more than 600,000 die from it each year. The best chance to reduce these numbers and save lives is through early detection and intervention. The investigators are developing a blood test to detect cancer from a simple blood …

    Stage

    Not phased

    Ages

    18 and older

    Site

    Exai Bio Inc., Palo Alto, California

    Locations

    2 in total

    Run by

    Exai Bio Inc.

    See if you can join NCT05833360 on ClinicalTrials.gov

11. A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

    The purpose of this research is to test whether a blood-based 3D genome conformation mapping test called the Episwitch CiRT® can help to identify likelihood of response to PD-(L)-1 checkpoint inhibitors (a class of cancer drugs) across multiple oncological indications by comparing the results to ac…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Eastern Connecticut Hematology and Oncology, Norwich, Connecticut

    Locations

    3 in total

    Run by

    Oxford Biodynamics Inc.

    See if you can join NCT06635954 on ClinicalTrials.gov

12. Trial of DFP-14927 in Advanced Solid Tumors

    This is a Phase I, open-label, single-arm, dose escalation study of DFP-14927 intravenous infusion administered to patients with refractory or relapsed solid tumors.

    Stage

    Phase 1

    Ages

    18 and older

    Site

    UCLA Department of Medicine- Hematology/Oncology, Los Angeles, California

    Locations

    2 in total

    Run by

    Delta-Fly Pharma, Inc.

    See if you can join NCT03943004 on ClinicalTrials.gov

13. TREC@TAMU Cancer Prevention Registry and Repository

    This study collects health and genetic information to implement cancer prevention and treatment strategies.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Texas A&M Family Care, Bryan, Texas

    Run by

    Texas A&M University

    See if you can join NCT06826014 on ClinicalTrials.gov

14. Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

    The investigators will recruit and enroll individuals that may have the KRAS-variant or other microRNA binding site mutations to join registry studies. The investigators will allow individuals to obtain their results through a physician at the completion of the studies. The investigators current fo…

    Stage

    Not phased

    Ages

    18 and older

    Site

    MiraKind, Los Angeles, California

    Run by

    MiraKind

    See if you can join NCT02253251 on ClinicalTrials.gov

15. A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

    This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of OR502 administered as a monotherapy and in combination with cemiplimab in subje…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    NEXT Austin, Austin, Texas

    Locations

    4 in total

    Run by

    OncoResponse, Inc.

    See if you can join NCT06090266 on ClinicalTrials.gov

16. Remote Temperature Monitoring of Patients At Risk for Developing Fever

    The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are: * does remote temperature monitoring reduce the number of days spent inpatient * what out-of-pocket cos…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Ellis Hospital, Schenectady, New York

    Run by

    AION Biosystems

    See if you can join NCT06752512 on ClinicalTrials.gov

17. Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

    A research study on the diagnosis of spread of disease for children who have been diagnosed with solid tumors using a new whole body imaging technique and a new MR contrast agent (ferumoxytol). Standard tests that are used to determine the extent and possible spread of a child's disease include mag…

    Stage

    Phase 1

    Ages

    6 to 40

    Site

    Stanford University Cancer Institute, Stanford, California

    Run by

    Heike E Daldrup-Link

    See if you can join NCT01542879 on ClinicalTrials.gov

18. Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

    This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab [Gazyva®] pre-treatment, by IV infusion, and in combination with pembrolizumab. A Phase 2 monotherapy arm is also planned;…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    HonorHealth Research Institute, Scottsdale, Arizona

    Locations

    6 in total

    Run by

    Simcha IL-18, Inc.

    See if you can join NCT04787042 on ClinicalTrials.gov

19. Occupational Exposures Among Firefighters

    This study aims to understand the effect of occupational exposures, including PFAS exposures, among firefighters.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Vincere Cancer Center, Scottsdale, Arizona

    Run by

    Vincere Cancer Center

    See if you can join NCT06173843 on ClinicalTrials.gov

20. A Crowd Sourcing Platform for Patients With Cancer

    All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.

    Stage

    Not phased

    Ages

    18 and older

    Site

    All4Cure, Seattle, Washington

    Run by

    All4Cure

    See if you can join NCT03530826 on ClinicalTrials.gov

21. Effects of Oncological Treatment During Pregnancy on Mother and Child

    The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Cooper University Hospital (2015-ongoing), Camden, New Jersey

    Locations

    33 in total

    Run by

    University Hospital, Gasthuisberg

    See if you can join NCT00330447 on ClinicalTrials.gov

22. Vincere Biobank Research Protocol

    The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Vincere Cancer Center, Scottsdale, Arizona

    Run by

    Vincere Cancer Center

    See if you can join NCT05954299 on ClinicalTrials.gov

23. Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up

    Proton therapy is a limited medical resource that is more expensive than conventional x-ray therapy. To correctly measure the success of proton therapy in treating different conditions, it is important to check a patient's health status after their treatment is finished. Checking on the progress of…

    Stage

    Not phased

    Ages

    Any age

    Site

    Ackerman Cancer Center, Jacksonville, Florida

    Locations

    3 in total

    Run by

    Center for Biomedical Research, LLC

    See if you can join NCT02070328 on ClinicalTrials.gov

24. Collection and Distribution of Biospecimens for Novel Research Uses

    iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagno…

    Stage

    Not phased

    Ages

    0 to 89

    Site

    iSpecimen, Huntsville, Alabama

    Locations

    2 in total

    Run by

    iSpecimen Inc

    See if you can join NCT03848962 on ClinicalTrials.gov

25. Phase I Human Analytics (HALO) Study

    Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clini…

    Stage

    Not phased

    Ages

    45 to 90

    Site

    Desert Medical Imaging, Indian Wells, California

    Run by

    HALO Diagnostics

    See if you can join NCT05423860 on ClinicalTrials.gov